In accordance While using the protocol, patients moving into the induction stage experienced nonresponse to at the least 2 oral AD medications ahead of randomization. The information presented is the number of Advert medications with nonresponse (defined as ?25% enhancement) taken for at least six weeks throughout The existing episode as attained f